Prehypertension
Conditions
Interventions
experimental group:Hydrochlorothiazide
control group:Placebo
Sponsors
Daping Hospital of Third Military Medical University
Eligibility
Sex/Gender
All
Age
45 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. The resident population of Chongqing municipality; 2. Aged >= 45 years; 3. Ambulatory blood pressure measurement is consistent with prehypertension (120-139/80-89mmHg); 4. Undiagnosed primary and/or secondary hypertension; 5. Not taking antihypertensive drugs; 6. Salt threshold screening for those who meet the high salt threshold; 7. Informed consent has been obtained and signed.
Exclusion criteria
Exclusion criteria: 1. There may be primary and/or secondary hypertension; 2. Patients with severe heart, liver, kidney, and endocrine system diseases, and the expected survival period is less than 3 years; 3. Those who have a history of allergy to this drug or its ingredients after taking it; 4. Participating in other clinical investigators; 5. Those with poor compliance or the researchers believe that they are not suitable for clinical trials for other reasons; 6. Those who suffer from factors such as disability, activity disorder, intellectual disability, etc., which may prevent normal participation in research and follow-up; 7. Patients who are judged by the doctor to be unable to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Morbidity of hypertension; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure;Atherosclerotic cardiovascular disease events; | — |
Countries
China
Contacts
Public ContactZeng Chunyu
Daping Hospital of Third Military Medical University
Outcome results
None listed